IMMX

Senn Sean

Known title: 10% OwnerCIK: 0001904837

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

IMMX Holds Shareholder and Analyst Call. Immix Biopharma hosted a shareholder and analyst conference call, sharing recent company updates and answering questions. The discussion gave participants insight into the company's current activities and outlook. Such calls can influence how investors view the business and its progress.

this person other insiders at IMMX

Transaction History

IMMX▼ Sell$550

We use analytics to understand how market-wall is used. No personal data is sold.